» Articles » PMID: 30181379

GanDouLing Combined with Penicillamine Improves Cerebrovascular Injury Via PERK/eIF2α/CHOP Endoplasmic Reticulum Stress Pathway in the Mouse Model of Wilson's Disease

Overview
Journal Biosci Rep
Specialty Cell Biology
Date 2018 Sep 6
PMID 30181379
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

We aim to investigate the function and mechanism of GanDouLing combinated with Penicillamine on cerebrovascular injury in Wilson's disease (WD). ELISA was performed to analyze the expression of vascular injury factors. Pathological changes of cerebral vessels were observed by HE stain. Immunohistochemistry assays were performed to analyze the expression of ICAM-1, VCAM-1, and GRP78. Western blotting was measured to analyze the expression of caspase-3, caspase-12, PERK, eIF2α, and CHOP. Apoptosis was detected with TUNEL assay. The expression of vascular injury factors and ICAM-1, VCAM-1 was significantly increased by WD and markedly decreased in GanDouLing-Penicillamine group. The expression of caspase-3, caspase-12, PERK, eIF2α, and CHOP were obviously expressed in Wilson group, GanDouLing-Penicillamine suppressed apoptosis and endoplasmic reticulum (ER) stress. Our findings suggested that GanDouLing-Penicillamine improved cerebrovascular injury through PERK/eIF2α/CHOP ER stress pathway in the mouse model of WD.

Citing Articles

Discussion on the Mechanism of Gandoufumu Decoction Attenuates Liver Damage of Wilson's Disease by Inhibiting Autophagy through the PI3K/Akt/mTOR Pathway Based on Network Pharmacology and Experimental Verification.

Tang L, Zhao C, Zhang J, Dong T, Chen H, Wei T Mediators Inflamm. 2023; 2023:3236911.

PMID: 37362448 PMC: 10287518. DOI: 10.1155/2023/3236911.


Integrated Metabolomics and Network Pharmacology to Reveal the Mechanisms of Gandouling Tablets Against Copper-Overload-Induced Neuronal Injury in Rats with Wilson's Disease.

Chen L, Xu W, Chen H, Han Y, Zhang Y Drug Des Devel Ther. 2023; 17:1763-1782.

PMID: 37333964 PMC: 10276572. DOI: 10.2147/DDDT.S409691.


Analysis of risk factors for neurological symptoms in patients with purely hepatic Wilson's disease at diagnosis.

Diao S, Zhuang Y, Huang Y, Zhou Z, Liu A, Hong M BMC Neurol. 2023; 23(1):89.

PMID: 36855079 PMC: 9972690. DOI: 10.1186/s12883-023-03105-w.


Gandouling Mitigates CuSO-Induced Heart Injury in Rats.

Fang S, Yang W, Zhang K, Peng C Animals (Basel). 2022; 12(19).

PMID: 36230444 PMC: 9559265. DOI: 10.3390/ani12192703.


System Pharmacology-Based Strategy to Decode the Synergistic Mechanism of GanDouLing for Wilson's Disease.

Zhang J, Chen H, Bao Y, Xie D, Yang W, Jiang H Evid Based Complement Alternat Med. 2021; 2021:1248920.

PMID: 33564316 PMC: 7864764. DOI: 10.1155/2021/1248920.


References
1.
Compston A . Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver, by S. A. Kinnier Wilson, (From the National Hospital, and the Laboratory of the National Hospital, Queen Square, London) Brain 1912: 34; 295-509. Brain. 2009; 132(Pt 8):1997-2001. DOI: 10.1093/brain/awp193. View

2.
Shoenfeld Y, Blank M, Sherer Y . Induction and treatment of the antiphospholipid syndrome--lessons from animal models. Eur J Clin Invest. 2001; 31(8):736-40. DOI: 10.1046/j.1365-2362.2001.00866.x. View

3.
Kadowaki H, Nishitoh H, Ichijo H . Survival and apoptosis signals in ER stress: the role of protein kinases. J Chem Neuroanat. 2004; 28(1-2):93-100. DOI: 10.1016/j.jchemneu.2004.05.004. View

4.
Xu C, Bailly-Maitre B, Reed J . Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest. 2005; 115(10):2656-64. PMC: 1236697. DOI: 10.1172/JCI26373. View

5.
Czlonkowska A, Gajda J, Rodo M . Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate. J Neurol. 1996; 243(3):269-73. DOI: 10.1007/BF00868525. View